Replies to post #225536 on Biotech Values

[DewDiligence]

TYME PR contains circular logic:

https://www.globenewswire.com/news-release/2019/09/09/1912684/0/en/TYME-Presents-Positive-Circulating-Tumor-Cell-Data-from-TYME-88-Panc-Study-in-Patients-with-Advanced-Pancreatic-Cancer-at-AACR-PANC-2019.html

TYME-88-PANC Phase II study showed patients being treated with SM-88, who achieved at least an 80% reduction in circulating tumor cell burden, demonstrated a 60% decrease in risk of death